158 related articles for article (PubMed ID: 33685392)
1. Construction of a bivalent vaccine against anthrax and smallpox using the attenuated vaccinia virus KVAC103.
Park DB; Ahn BE; Son H; Lee YR; Kim YR; Jo SK; Chun JH; Yu JY; Choi MM; Rhie GE
BMC Microbiol; 2021 Mar; 21(1):76. PubMed ID: 33685392
[TBL] [Abstract][Full Text] [Related]
2. Development of an attenuated smallpox vaccine candidate: The KVAC103 strain.
Lim H; In HJ; Kim YJ; Jang S; Lee YH; Kim SH; Lee SH; Park JH; Yang HJ; Yoo JS; Lee SW; Kim MY; Chung GT; Yeo SG
Vaccine; 2021 Aug; 39(36):5214-5223. PubMed ID: 34334254
[TBL] [Abstract][Full Text] [Related]
3. Live attenuated smallpox vaccine candidate (KVAC103) efficiently induces protective immune responses in mice.
Hwang YH; Byeon Y; Ahn SH; Kim MY; Byun SH; Lee HJ; Suh B; Kim D; Jung EJ; Kim YJ
Vaccine; 2024 Feb; 42(6):1283-1291. PubMed ID: 38310019
[TBL] [Abstract][Full Text] [Related]
4. Development of a highly efficacious vaccinia-based dual vaccine against smallpox and anthrax, two important bioterror entities.
Merkel TJ; Perera PY; Kelly VK; Verma A; Llewellyn ZN; Waldmann TA; Mosca JD; Perera LP
Proc Natl Acad Sci U S A; 2010 Oct; 107(42):18091-6. PubMed ID: 20921397
[TBL] [Abstract][Full Text] [Related]
5. Mucosal immunization with a novel nanoemulsion-based recombinant anthrax protective antigen vaccine protects against Bacillus anthracis spore challenge.
Bielinska AU; Janczak KW; Landers JJ; Makidon P; Sower LE; Peterson JW; Baker JR
Infect Immun; 2007 Aug; 75(8):4020-9. PubMed ID: 17502384
[TBL] [Abstract][Full Text] [Related]
6. Vaccination of BALB/c mice with Escherichia coli-expressed vaccinia virus proteins A27L, B5R, and D8L protects mice from lethal vaccinia virus challenge.
Berhanu A; Wilson RL; Kirkwood-Watts DL; King DS; Warren TK; Lund SA; Brown LL; Krupkin AK; Vandermay E; Weimers W; Honeychurch KM; Grosenbach DW; Jones KF; Hruby DE
J Virol; 2008 Apr; 82(7):3517-29. PubMed ID: 18199639
[TBL] [Abstract][Full Text] [Related]
7. BA3338, a surface layer homology domain possessing protein augments immune response and protection efficacy of protective antigen against Bacillus anthracis in mouse model.
Kumar M; Puranik N; Varshney A; Tripathi N; Pal V; Goel AK
J Appl Microbiol; 2020 Aug; 129(2):443-452. PubMed ID: 32118336
[TBL] [Abstract][Full Text] [Related]
8. A novel live attenuated anthrax spore vaccine based on an acapsular Bacillus anthracis Sterne strain with mutations in the htrA, lef and cya genes.
Chitlaru T; Israeli M; Rotem S; Elia U; Bar-Haim E; Ehrlich S; Cohen O; Shafferman A
Vaccine; 2017 Oct; 35(44):6030-6040. PubMed ID: 28342664
[TBL] [Abstract][Full Text] [Related]
9. Enhanced immunogenicity and protective effect conferred by vaccination with combinations of modified vaccinia virus Ankara and licensed smallpox vaccine Dryvax in a mouse model.
Meseda CA; Garcia AD; Kumar A; Mayer AE; Manischewitz J; King LR; Golding H; Merchlinsky M; Weir JP
Virology; 2005 Sep; 339(2):164-75. PubMed ID: 15993917
[TBL] [Abstract][Full Text] [Related]
10. Protection against anthrax with recombinant virus-expressed protective antigen in experimental animals.
Iacono-Connors LC; Welkos SL; Ivins BE; Dalrymple JM
Infect Immun; 1991 Jun; 59(6):1961-5. PubMed ID: 1903769
[TBL] [Abstract][Full Text] [Related]
11. Electroporation of a multivalent DNA vaccine cocktail elicits a protective immune response against anthrax and plague.
Albrecht MT; Livingston BD; Pesce JT; Bell MG; Hannaman D; Keane-Myers AM
Vaccine; 2012 Jul; 30(32):4872-83. PubMed ID: 22633906
[TBL] [Abstract][Full Text] [Related]
12. An intranasal vaccine targeting both the Bacillus anthracis toxin and bacterium provides protection against aerosol spore challenge in rabbits.
Wimer-Mackin S; Hinchcliffe M; Petrie CR; Warwood SJ; Tino WT; Williams MS; Stenz JP; Cheff A; Richardson C
Vaccine; 2006 May; 24(18):3953-63. PubMed ID: 16530302
[TBL] [Abstract][Full Text] [Related]
13. Enhancement of antibody responses to Bacillus anthracis protective antigen domain IV by use of calreticulin as a chimeric molecular adjuvant.
Park YS; Lee JH; Hung CF; Wu TC; Kim TW
Infect Immun; 2008 May; 76(5):1952-9. PubMed ID: 18285494
[TBL] [Abstract][Full Text] [Related]
14. Towards a human oral vaccine for anthrax: the utility of a Salmonella Typhi Ty21a-based prime-boost immunization strategy.
Baillie LW; Rodriguez AL; Moore S; Atkins HS; Feng C; Nataro JP; Pasetti MF
Vaccine; 2008 Nov; 26(48):6083-91. PubMed ID: 18805452
[TBL] [Abstract][Full Text] [Related]
15. Generation of a novel chimeric PALFn antigen of Bacillus anthracis and its immunological characterization in mouse model.
Suryanarayana N; Verma M; Thavachelvam K; Saxena N; Mankere B; Tuteja U; Hmuaka V
Appl Microbiol Biotechnol; 2016 Oct; 100(19):8439-51. PubMed ID: 27364624
[TBL] [Abstract][Full Text] [Related]
16. A bivalent protein r-PB, comprising PA and BclA immunodominant regions for comprehensive protection against Bacillus anthracis.
Majumder S; Das S; Somani V; Makam SS; Joseph KJ; Bhatnagar R
Sci Rep; 2018 May; 8(1):7242. PubMed ID: 29740033
[TBL] [Abstract][Full Text] [Related]
17. Vaccinia virus strain LC16m8 defective in the B5R gene keeps strong protection comparable to its parental strain Lister in immunodeficient mice.
Yokote H; Shinmura Y; Kanehara T; Maruno S; Kuranaga M; Matsui H; Hashizume S
Vaccine; 2015 Nov; 33(45):6112-9. PubMed ID: 26241947
[TBL] [Abstract][Full Text] [Related]
18. Development of a multiple-antigen protein fusion vaccine candidate that confers protection against Bacillus anthracis and Yersinia pestis.
Gallagher TB; Mellado-Sanchez G; Jorgensen AL; Moore S; Nataro JP; Pasetti MF; Baillie LW
PLoS Negl Trop Dis; 2019 Aug; 13(8):e0007644. PubMed ID: 31430284
[TBL] [Abstract][Full Text] [Related]
19. Increased long-term immunity to Bacillus anthracis protective antigen in mice immunized with a CIA06B-adjuvanted anthrax vaccine.
Wui SR; Han JE; Kim YH; Rhie GE; Lee NG
Arch Pharm Res; 2013 Apr; 36(4):464-71. PubMed ID: 23440578
[TBL] [Abstract][Full Text] [Related]
20. A combination of the TLR4 agonist CIA05 and alum promotes the immune responses to Bacillus anthracis protective antigen in mice.
Wui SR; Kim HK; Han JE; Kim JM; Kim YH; Chun JH; Cho YJ; Lee NG
Int Immunopharmacol; 2011 Sep; 11(9):1195-204. PubMed ID: 21492746
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
